Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-06-043805
Filing Date
2006-03-02
Accepted
2006-03-02 15:25:15
Documents
12
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1406256
2 EQUITY COMPENSATION PLAN FOR DIRECTORS dex10235.htm EX-10.235 23728
3 EQUITY COMPENSATION PLAN FOR EXECUTIVE OFFICERS dex10236.htm EX-10.236 25890
4 FORM OF NONQUALIFIED STOCK OPTION AWARD AGREEMENT FOR DIRECTORS dex10237.htm EX-10.237 28305
5 EQUITY COMPENSATION PLAN FOR ALL NON-DIRECTOR PARTICIPANTS dex10238.htm EX-10.238 32443
6 LEASE AGREEMENT dex10239.htm EX-10.239 21643
7 SUBSIDIARIES OF THE REGISTRANT dex21.htm EX-21 30678
8 CONSENT OF DELOITTE & TOUCHE LLP dex231.htm EX-23.1 1608
9 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9232
10 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9280
11 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 2695
12 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 2883
  Complete submission text file 0001193125-06-043805.txt   1596064
Mailing Address 3151 SOUTH 17TH ST WILMINGTON NC 28412
Business Address 3151 SOUTH 17TH ST WILMINGTON NC 28412 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

EIN.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27570 | Film No.: 06659643
SIC: 8731 Services-Commercial Physical & Biological Research